|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Bellicum Pharmaceuticals, Inc (BLCM) |
|
|
$0.07 0.00 (0.00%) as of 4:30 Mon 3/4
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
6,100,000 |
Market
Cap: |
455.98(K) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.0745 - $0.96 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing controllable cellular immunotherapies for the treatment of various forms of cancer. Co. is developing chimeric antigen receptors (CAR)-T cell therapies, which are an approach in which a patient's or donor's T cells are genetically modified to carry CARs. By incorporating its switch technologies, Co. is developing product candidates in various areas of cellular immunotherapy including BPX-601, which is designed to treat solid tumors expressing prostate stem cell antigen; and BPX-603, which is designed to target solid tumors that express the human epidermal growth factor receptor 2 antigen.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Naeve Gregory S. |
Chief Business Officer |
|
2019-01-02 |
4 |
D |
$3.33 |
$3,307 |
D/D |
(993) |
14,441 |
|
- |
|
Naeve Gregory S. |
Chief Business Officer |
|
2019-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,031 |
15,434 |
|
- |
|
Spencer David M. |
Chief Technology Officer |
|
2019-01-02 |
4 |
D |
$3.33 |
$3,137 |
D/D |
(942) |
91,497 |
|
- |
|
Spencer David M. |
Chief Technology Officer |
|
2019-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
92,439 |
|
- |
|
Smith Alan K. |
EVP, Technical Operations |
|
2019-01-02 |
4 |
D |
$3.33 |
$2,940 |
D/D |
(883) |
3,548 |
|
- |
|
Smith Alan K. |
EVP, Technical Operations |
|
2019-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,344 |
4,431 |
|
- |
|
Williams Rosemary Y. |
Principal Accounting Officer |
|
2019-01-02 |
4 |
D |
$3.33 |
$1,608 |
D/D |
(483) |
3,984 |
|
- |
|
Williams Rosemary Y. |
Principal Accounting Officer |
|
2019-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,281 |
4,467 |
|
- |
|
Stonehouse Jon P |
Director |
|
2018-11-09 |
4 |
B |
$4.56 |
$45,600 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
Spencer David M. |
Chief Technology Officer |
|
2018-09-04 |
4 |
AS |
$7.04 |
$70,413 |
D/D |
(10,000) |
89,939 |
|
- |
|
Naeve Gregory S. |
Chief Business Officer |
|
2018-08-21 |
4 |
D |
$6.74 |
$10,764 |
D/D |
(1,597) |
13,403 |
|
- |
|
Spencer David M. |
Chief Technology Officer |
|
2018-07-18 |
4 |
AS |
$7.63 |
$305,132 |
D/D |
(40,000) |
99,939 |
|
- |
|
Ward Shane |
Sr. VP and General Counsel |
|
2018-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
Musso Alan A |
CFO and Treasurer |
|
2018-05-25 |
4 |
AS |
$7.97 |
$49,466 |
D/D |
(6,206) |
26,548 |
|
- |
|
Grossman William |
Sr. VP, Chief Medical Officer |
|
2018-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
Baker Julian |
10% Owner |
|
2018-01-19 |
4 |
S |
$7.91 |
$2,336,217 |
I/I |
(295,361) |
58,131 |
|
- |
|
Baker Julian |
10% Owner |
|
2018-01-18 |
4 |
S |
$8.12 |
$2,635,768 |
I/I |
(324,774) |
62,267 |
|
- |
|
Baker Julian |
10% Owner |
|
2018-01-17 |
4 |
S |
$8.63 |
$2,247,910 |
I/I |
(260,600) |
66,815 |
|
- |
|
Smith Alan K. |
EVP, Technical Operations |
|
2018-01-09 |
4 |
AS |
$9.40 |
$4,578 |
D/D |
(487) |
2,087 |
|
- |
|
Spencer David M. |
Chief Scientific Officer |
|
2018-01-03 |
4 |
D |
$9.79 |
$5,766 |
D/D |
(589) |
139,939 |
|
- |
|
Spencer David M. |
Chief Scientific Officer |
|
2018-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
140,528 |
|
- |
|
Musso Alan A |
CFO and Treasurer |
|
2018-01-03 |
4 |
D |
$9.79 |
$6,912 |
D/D |
(706) |
32,754 |
|
- |
|
Musso Alan A |
CFO and Treasurer |
|
2018-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,875 |
33,460 |
|
- |
|
Moseley Ken |
Sr. VP and General Counsel |
|
2018-01-03 |
4 |
D |
$9.79 |
$5,766 |
D/D |
(589) |
1,465 |
|
- |
|
Moseley Ken |
Sr. VP and General Counsel |
|
2018-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
2,054 |
|
- |
|
179 Records found
|
|
Page 3 of 8 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|